The offering includes: €850 million floating rate notes, due March 2027, bearing interest at 3-month Eur...
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...
SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...
China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (B...
Taiwan-based Health2Sync, a leading digital health company specialising in chronic disease management, has raised over $...
Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...
Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...
Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload an...
It is never lost on me or my team at MTPConnect that there is a paucity of funding allocated to women’s health res...
This year marks the 10th anniversary of the International Day of Women in STEM, highlighting a decade of progress in clo...
Degrader-antibody conjugates (DACs) represent a natural evolution in targeted precision medicines for oncology and other...
Over the past decade, interest in Antibody-Drug Conjugates (ADCs) has surged, driven by their promise for patients, adva...
Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...
Which products are currently under development? 2025 will be a defining year for Caliway as we push ahead with key clin...
By 2030, pharmaceutical companies are expected to lose over $236 billion in revenue due to the impending ‘patent c...
Malaysia is facing a growing environmental and public health threat due to improper disposal of pharmaceutical wast...
